Improving Glycaemic Control in Patients With Type 2 Diabetes Mellitus Through Peer Support Instant Messaging
NCT ID: NCT04797429
Last Updated: 2025-05-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
68 participants
INTERVENTIONAL
2020-11-01
2025-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Real-time Engagement for Learning to Effectively Control Type 2 Diabetes
NCT06375460
Improving Diabetes Care With Patient Decision Aids - A Trial in Community-based Primary Care
NCT00668590
Clinic to Community Navigation to Improve Diabetes Outcomes
NCT03474731
ENhancing Outcomes Through Goal Assessment and Generating Engagement in Diabetes Mellitus
NCT02910089
Pilot-Testing Strategies to Improve Outcomes for Youth With Type 2 Diabetes by Addressing Health-Related Social Needs
NCT07216118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
The intervention group will receive antidiabetic therapy according to the current guidelines but with the additional opportunity to use the peer support IMS tool. Peer support and moderation of the intervention group will be provided by moderators. Moderators will be supervised by a dietitian.
Peer Support Intervention via Instant Messaging Service Tool (IMS-Tool)
Peer Support via the IMS-tool increases diabetes self-management, improves self-efficiacy, adherence and glycaemic control
control group
The control group receives the antidiabetic therapy according to the current guidelines, but without having access to the IMS tool. This means that participants receive medical treatment by their practitioner according to the Austrian recommendations.
antidiabetic therapy according to the current guidelines
In contrast, the control group has to manage their diabetes mellitus type 2 with standard support and without online exchange.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Peer Support Intervention via Instant Messaging Service Tool (IMS-Tool)
Peer Support via the IMS-tool increases diabetes self-management, improves self-efficiacy, adherence and glycaemic control
antidiabetic therapy according to the current guidelines
In contrast, the control group has to manage their diabetes mellitus type 2 with standard support and without online exchange.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HbA1c of ≥ 6.5% (48 mmol/mol) at the last measurement
* receive the antidiabetic therapy according to the current guidelines
* older than 40 years
* living in Lower Austria
* get oral hyperglycaemic agents for maximum three years
* understand the individual commitments during trial
* must be able to visit training and measurements
* diagnosed type 2 diabetes mellitus according to the Austrian definition
* HbA1c of ≥ 6.5% (48 mmol/mol) at the last measurement
* receive the antidiabetic therapy according to the current guidelines
* get oral hyperglycaemic agents for three years minimum
* older than 60 years
* living in the vicinity of the training location in St. Pölten, which means residing in St. Pölten, St. Pölten Land, Melk, Krems, or Lilienfeld
* engaged participating (= regular participation) in the Austrian disease management program 'Therapie aktiv - Diabetes im Griff'
* understand the individual commitments during trial
* must be able to visit training and measurements
* commitment to undergo the moderator training
Exclusion Criteria
* eye disorders that severely limit vision and, hence, inability to read the display (e.g., proliferative retinopathy or macular edema)
* severe illnesses such as kidney, liver, heart disease, or malignant cancer, neurological of mental illness which make a longer hospitalization likely
* substance abuse
* pregnancy
* limitation in the German language
* unable to visit training and measurements
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Karl Landsteiner University of Health Sciences
OTHER
Austrian Health Insurance Fund
UNKNOWN
St. Pölten University of Applied Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sankt Pölten University of Applied Sciences
Sankt Pölten, Lower Austria, Austria
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hold E, Grublbauer J, Wiesholzer M, Wewerka-Kreimel D, Stieger S, Kuschei W, Kisser P, Gutzer E, Hemetek U, Ebner-Zarl A, Pripfl J. Improving glycemic control in patients with type 2 diabetes mellitus through a peer support instant messaging service intervention (DiabPeerS): study protocol for a randomized controlled trial. Trials. 2022 Apr 14;23(1):308. doi: 10.1186/s13063-022-06202-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LS18-021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.